Obsidian Therapeutics (OBX) News
NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.00-0.15 (-1.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OBX news summary
We found 3 recent headlines mentioning Obsidian Therapeutics (OBX): 0 in the past week and 3 in the past 30 days, most often from Seeking Alpha, Business Wire, Nasdaq. For price context, OBX is down 1.23% at $12.00. The most recent story, "Obsidian Therapeutics, Inc. reports Q3 results", was published by Seeking Alpha on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Obsidian Therapeutics headlines
- Obsidian Therapeutics, Inc. reports Q3 resultsSeeking Alpha
- Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business UpdatesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (“Obsidian”) (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop…Business Wire
- Healthcare Stocks Advance: OBX Surges 38%, ONCO Gains 32%, TMDX Rises 26%(RTTNews) - Healthcare stocks moved higher following clinical, financial and corporate updates. Developments included positive melanoma therapy data, a reverse stock split, stronger quarterly…NasdaqBCTX, DAVI, OBX, ONCO